Dialogue Sometimes Tumors Vanish, but Improvements Still Needed for CAR T-Cell Immunotherapy Nov. 19, 2020 Facebook Twitter LinkedIn Email Skip breadcrumb URMC Home Newsroom Publications Dialogue Sometimes Tumors Vanish, but Improvements Still Needed for CAR T-Cell Immunotherapy Wilmot Poised to Lead Research and Treatment to Improve Access, Results